Skip to main content
. 2020 Nov 19;2020:9850351. doi: 10.1155/2020/9850351

Figure 1.

Figure 1

Seroprevalence of neutralizing antibodies against EV-A71, CV-A6, and CV-A16 by age group in sample 1 and geometric mean titers (GMTs) distribution in the positive serum samples.